CD79A and COVID-19: All anti-SARS-CoV-2 immunoglobulins analyzed showed increased levels with HERV-W ENV expression in acute COVID-19 cases, with the exception of IgA (Figure 4), an observation that may explain the more severe evolution and symptoms already reported in this subgroup of acute COVID-19 patients (20, 21).